ArticleInternational journal of emergency medicine2026
Early adjunctive local block therapy improves pain and limb swelling after Gloydius envenomation: a propensity score-adjusted retrospective cohort study in the emergency department.
Article in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSnakebite envenomation remains a major neglected tropical disease worldwide and frequently results in substantial local tissue injury despite timely antivenom therapy. Effective adjunctive strategies for early local symptom control are still limited. We aimed to evaluate whether early local block therapy (LBT) is associated with improved pain and limb swelling outcomes in patients with Gloydius envenomation.
methodsWe conducted a single-center retrospective cohort study including 203 adult patients with confirmed Gloydius envenomation between 2019 and 2024. Patients were categorized according to receipt of LBT (perilesional lidocaine, dexamethasone, and α-chymotrypsin) in addition to standard care. Primary outcomes were reduction in limb swelling (change in limb circumference from admission to Day 3) and pain relief (change in VAS score within 48 h). Secondary outcome was length of hospital stay (LOS). Multivariable linear regression and propensity score-based analyses were performed to adjust for potential confounders, including baseline wound infection.
resultsBaseline wound infection was more frequent in the LBT group than in controls (41.3% vs. 25.2%, P = 0.015). After full adjustment, LBT remained independently associated with greater limb swelling reduction (adjusted β = 2.31 cm; 95% CI 2.08-2.54; P < 0.001) and greater pain relief (adjusted β = 2.13 points; 95% CI 1.83-2.43; P < 0.001). Findings were consistent across propensity score-matched and weighted analyses. LBT was not associated with prolonged hospitalization (adjusted β = -0.98 days; P = 0.066).
conclusionsIn this real-world cohort, early adjunctive LBT was associated with clinically meaningful improvement in local symptoms without evidence of increased hospital stay. These findings support LBT as a potential adjunctive strategy for hemotoxic snakebite and warrant prospective validation in multicenter prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.